MPBA 3RD QUARTER 2020 FOR WEB

N T N EO T ECH, LLC Core vaccines for the life of your pet.

For more informa�on: Please contact Dr. Ben Hatler: 1.877.636.8324 Fax: 731.364.5860 Email: ben@neotechvaccines.com

Will N EO P AR ® (canine parvovirus vaccine) override maternal an�bodies in young puppies?

In our study, fi�y-two 3 week old puppies (18 to 21 days of age) were administered a 1cc dose of N EO P AR ® . Prior to vaccina�on a blood sample taken from each of the 52 puppies indicated pre-exis�ng CPV (canine parvovirus) maternal an�bodies were present (range: 32 to 3,162; average of 522). Independent researchers have reported that a CPV maternal an�body �ter of 20 or higher can block conven�onal vaccines from s�mula�ng protec�on. Fourteen days a�er vaccina�on (at five weeks of age) a second blood sample was collected to determine the level of vaccine induced CPV an�body. Ninety percent of the puppies had a posi�ve vaccine induced CPV an�body response to only one dose of N EO P AR ® . A posi�ve vaccine induced CPV an�body response is defined as having at least a 4 fold increase in the an�body level between the before and the 14 day post vaccina�on blood sample.

Summary of CPV antibody levels * average pre vaccination maternal antibody level 522 **

® Percentage of 3 week old puppies with a posi�ve vaccine induced CPV an�body response to one dose of N EO P AR

range of pre vaccination maternal antibody level frequency of vaccine induced antibody range of positive vaccine induced antibody level average positive vaccine induced antibody level

32 to 3,162

90%

47 of 52 (90%)

2,138 to 1,000,000

43,989

* CPV an�body levels are reported as the dilu�on of serum that neutralizes CPV in a constant virus-varying serum assay. ** Studies indicate that a maternal an�body of 20 prevents conven�onal vaccines from inducing a posi�ve CPV an�body response

10%

Posi�ve vaccine induced CPV an�body response No vaccine induced CPV an�body response

N EO T ECH, LLC is a United States Department of Agriculture licensed veterinary vaccine manufacturer that strictly adheres to the core vaccine principle endorsed by veterinarians, scien�sts, and dog enthusiasts. N EO T ECH, LLC’s philosophy towards vaccina�on of dogs is simple. Avoid over-vaccina�on of dogs by only using simple and potent vaccines. N EO T ECH, LLC has a 40 year history of enhancing animal well-being and helping animals live quality lives. N EO T ECH, LLC’s N EO P AR ® is a single an�gen vaccine. It has proven superior protec�on and less likely to produce a reac�on than complex combina�on vaccines. Yes, even in the presence of high maternal an�bodies, N EO P AR ® induced a high protec�ve level of CPV an�bodies against the #1 viral disease of puppies.

h�ps://neotechvaccines.com

COME HEAR BEN HATLER SPEAK ON IMMUNIZATIONS AT THE MPBA CONFERENCE IN MARCH 2020! 30

Made with FlippingBook Learn more on our blog